Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Early hair loss may indicate future prostate issues.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

Urinary PSA could be an early marker for enlarged prostate.

Suppressing certain hormones might help prevent prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Finasteride for hair loss has minimal impact on sexual function.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Ganoderma lucidum may help treat enlarged prostate in rats.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Berberine may reduce prostate enlargement by blocking inflammation.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.